Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
Main Authors: | Boykin, C, Zhang, G, Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304433/ |
Similar Items
-
VASP Activation via the Gα13/RhoA/PKA Pathway Mediates Cucurbitacin-B-Induced Actin Aggregation and Cofilin-Actin Rod Formation
by: Zhang, Yan-Ting, et al.
Published: (2014) -
STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
by: Oi, Toru, et al.
Published: (2016) -
Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation
by: Timofeeva, Olga A., et al.
Published: (2012) -
A JAK/STAT invasion
by: Wells, William A.
Published: (2002) -
JAKs and STATs in chemoresistance
by: Costa-Pereira, Ana P
Published: (2010)